Zhimeng Biopharma

About:

Zhimeng is also actively developing novel small molecule drugs to treat neurological diseases, such as epilepsy, pains and strokes.

Website: http://www.core-biopharma.com/

Top Investors: Shenzhen Capital Group, Co-Stone Venture Capital, Fortune Venture Capital, Advantech Capital, Dyee Capital

Description:

Zhimeng is also actively developing novel small molecule drugs to treat neurological diseases, such as epilepsy, pains and strokes.